Tocilizumab for severe COVID-19: A promising intervention affecting inflammation and coagulation

Detalles Bibliográficos
Autor principal: Levi, Marcel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Federation of Internal Medicine. Published by Elsevier B.V. 2020
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7229910/
https://www.ncbi.nlm.nih.gov/pubmed/32425364
http://dx.doi.org/10.1016/j.ejim.2020.05.018

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7229910/
https://www.ncbi.nlm.nih.gov/pubmed/32425364
http://dx.doi.org/10.1016/j.ejim.2020.05.018

Ejemplares similares